Navigation Links
Nature's Bioceuticals Develops New Formula For Men With Enlarged Prostate
Date:12/8/2011

ese medicines are all natural and derived from botanicals and mineral bases. Nature's Bioceuticals strives to provide high quality natural medicines that are as effective, if not more effective, than synthetic drugs and more importantly do not have the negative side effects usually associated with many of today's prescribed drugs.

Nature's line of natural medicines will be either sold as prescription drugs, if applied for by the company and approved by the FDA, or sold as dietary supplements under the Dietary Supplement Health and Education Act of 1994, commonly referred to as "DSHEA".

In addition to historical information, this release contains forward-looking statements. Mistral Ventures, Inc. and/or Nature's Bioceuticals may, from time to time, make written or oral forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements encompass Mistral Ventures, Inc. and/or Nature's Bioceuticals beliefs, expectations, hopes, or intentions regarding future events. Words such as "expects," "intends," "believes," "anticipates," "should," "likely," and similar expressions identify forward-looking statements. All forward-looking statements included in this release are made as of the date hereof and are based on information available to the Company as of such date. Mistral Ventures, Inc. nor Nature's Bioceuticals assume any obligation to update any forward-looking statement. Actual results will vary, and may vary materially, from those anticipated, estimated, projected or expected for a number of reasons, including, among others: further reviews of the Company's financial statements by the Company and its Audit Committee; modification of the Company's accounting practices; foreign business risks; industry cyclicality; fluctuations in customer demand and order pattern; changes in pricing and general economic conditions; as well as other risks that may be delineated from time to time or filed with the SEC.'/>"/>

SOURCE Mistral Ventures, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. VolitionRX Subsidiary Enters Into its First Revenue-Generating Agreement to Profile Blood-Based Epigenetic Signatures
2. Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women
3. Siemens Corporate Research Develops RAPID2 System for Fast Discovery of Discriminative Pathogen Signatures
4. Natures Bioceuticals Finalizes Agreement for the Purchase of Proprietary Weight Loss Formula
5. Natures Bioceuticals Finalizes The Purchase of Cold and Flu Formula
6. Natures Bioceuticals Tears Into the Multi-Billion Dollar Chronic Kidney Disease Market
7. Ecology Coatings Develops UV-Curable Coatings for Medical Wristbands
8. MedBox Develops Patent-Pending System for Storage and Retrieval of Prescription Drugs
9. Unilife Develops Proprietary Portfolio of Wearable Subcutaneous Infusion Devices for the Self-Administration of Large Volume Drugs by Patients
10. Unilife Develops Proprietary Range of Auto-Injectors for Patient Self-Administration of Injectable Drugs
11. Unilife Develops Unifill® EZMix Multiple-Chamber Prefilled Syringes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... LEBANON, N.J. and BETHESDA, Md. ... clinical development-stage immunotherapy company focused on treating and preventing ... Phase 2-stage, anti-IL-15 monoclonal antibody (AMG 714) from Amgen ... this exclusive license agreement, Celimmune has the rights to ... basis excluding Japan . Concurrently, Amgen ...
(Date:3/2/2015)... ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced that it ... 2014 on March 9, 2015. The Company also plans to hold ... 2015, at 5:00 pm ET. The call will be hosted by ... , , , LIVE CALL:  , , , (877) ... , , , , , , ...
(Date:3/1/2015)... , March 1, 2015  Patients suffering from ... against this debilitating foot ailment, according to research ... ,s Annual Scientific Meeting . Researchers utilized ... emulsify and remove diseased fasciitis tissue. Permanently removing ... to regrow in its place, restoring normal function. ...
Breaking Medicine Technology:Celimmune Announces Anti-IL-15 Antibody Licensing and Option Agreements with Amgen 2Celimmune Announces Anti-IL-15 Antibody Licensing and Option Agreements with Amgen 3ImmunoCellular Therapeutics to Report 2014 Financial Results on March 9, 2015; a Business Update Conference Call and Webcast is Scheduled for March 12, 2015 2Interventional radiology treatment relieves chronic plantar fasciitis 2Interventional radiology treatment relieves chronic plantar fasciitis 3
... Neuradiab(TM) compares favorably to data from other, ... 17 /PRNewswire-FirstCall/ - Bradmer Pharmaceuticals Inc.,(TSX: BMR), a ... cancer therapies, today released progression free,survival (PFS) data ... in glioblastoma multiforme (GBM) patients. As an exploratory,endpoint ...
... Conn., July 16 Biodel Inc. (Nasdaq:,BIOD) today announced ... now complete, with the last study patient visit on ... released either at Biodel,s poster,presentation at the European Association ... 2008, or at a later appropriate scientific forum., ...
Cached Medicine Technology:Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials 2Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials 3Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials 4Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials 5Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program 2Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program 3Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program 4Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program 5
(Date:3/2/2015)... Atlantic Information Services, Inc. (AIS) is ... of Health Plans: 2015 , the all-new 12th edition ... health plan market, with enrollment data and contact information ... , Available as a printed book containing the full ... quick-view tables and charts, as well as an electronic ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 What are ... should physicians request references? When are interviews scheduled, how ... employment opportunities?, Both training and practicing physicians who are ... these questions and more at the PracticeLink Physician Career ... The drop-in Job Fair is from 5:30 to 8:30 ...
(Date:3/2/2015)... Viejo, California (PRWEB) March 02, 2015 ... release of the TranStatic Volume 2 from Pixel Film Studios. ... transitions made exclusively for FCPX,” said Christina Austin, CEO of ... to have in any Final Cut Pro X editors toolbox.” ... scene to the next with media altering static scrambling effects ...
(Date:3/1/2015)... is pleased to announce the addition of a digital library ... over 75 terms and phrases available for viewing, with more being ... a better understanding of what our Providers are talking about when ... this resource, our patients are able to go back to the ... they may not remember or comprehend at the time of their ...
(Date:3/1/2015)... New York (PRWEB) March 01, 2015 ... hip lawsuit (( http://www.consumerinjurylawyers.com/wright-profemur-hip-replacement ) scheduled to go ... defense must prepare a witness to provide testimony ... in the development of the Profemur device, Bernstein ... in U.S. District Court, Northern District of Iowa ...
Breaking Medicine News(10 mins):Health News:Now Available from AIS: 12th Edition of Annual Book Containing Health Plan Enrollment Data, Contact Information 2Health News:PracticeLink to Host a Career Advancement Workshop and Job Fair in Houston 2Health News:Pixel Film Studios released the TranStatic Volume 2 plugin for Final Cut Pro X today 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 3
... ... Valuable Incentives Are Still Available , ... (Vocus) April 20, 2010 -- Toll Brothers, the nation,s leading builder of luxury ... 24 until May 2. With the slight rise in interest rates recently, and conventional wisdom ...
... ... nutritional products and services exclusive to health care professionals, announced today the nationwide launch ... ... Inc. , a leading national provider of nutritional products and services exclusive to health ...
... next decade to protect public health , TUESDAY, April 20 ... take steps to lower the amount of salt in the ... Tuesday. , In a report from the Institute of Medicine, ... the federal government on public health issues, the panel recommended ...
... ... designed to help the immune system; to return the gut back to health after antibiotics, ... the company that brought Waterfall D-Mannose to the world. , ... (PRWeb UK) April 19, 2010 -- The natural health products ...
... 2010 Elsevier, the world-leading publisher of scientific, technical ... the Faculty of Travel Medicine of the Royal College ... Travel Medicine and Infectious Disease has been ... of Travel Medicine. RCPSG,s Faculty of Travel ...
... multi-center study led by a researcher at Rhode Island ... hemodialysis patients are at increased risk of carrying methicillin-resistant ... study also found that patients have vastly different quantities ... their risk of developing an infection after surgery. The ...
Cached Medicine News:Health News:Spring Into A New Toll Brothers Dream Home During the National Spring Sales Event April 24 - May 2 2Health News:Spring Into A New Toll Brothers Dream Home During the National Spring Sales Event April 24 - May 2 3Health News:Spring Into A New Toll Brothers Dream Home During the National Spring Sales Event April 24 - May 2 4Health News:New Designs for Health Probiotic Toothpaste -- A Breakthrough in Oral Health 2Health News:New Designs for Health Probiotic Toothpaste -- A Breakthrough in Oral Health 3Health News:New Designs for Health Probiotic Toothpaste -- A Breakthrough in Oral Health 4Health News:New Designs for Health Probiotic Toothpaste -- A Breakthrough in Oral Health 5Health News:Experts Urge FDA to Lower Salt in American Diet 2Health News:Experts Urge FDA to Lower Salt in American Diet 3Health News:Experts Urge FDA to Lower Salt in American Diet 4Health News:Anna & John's Special Probiotic Blend™ Just Released by Sweet Cures™, the Innovative Natural Health Products Company based in York, UK 2Health News:Who is at risk for MRSA? 2
... has been a key participant in the ... than a decade. Previous Medtronic autotransfusion systems ... platelets, as well as to determine requirements ... platelet-rich plasma (PRP) for a small amount ...
This unique hemostatic seal provides a simple option for beating heart CABG anastomoses, allowing you to use your own hand-suturing technique without the release of cerebral emboli associated with th...
... System combines low-profile, high radial force, and excellent ... compatible stent system provides 6F sheath / 8F ... 10.0 mm). Now, with longer stents available, the ... lengths (28, 38, 56, 80 and 100 mm) ...
... Supreme and Response catheters comprise the ... available for electrophysiology procedures. Their advanced ... for superior torque response with a ... curves and French sizes, Supreme and ...
Medicine Products: